Literature DB >> 16247751

Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: a substudy from the Breathing Not Properly (BNP) Multinational Study.

Alan H B Wu1, Torbjørn Omland, Cathrine Wold Knudsen, James McCord, Richard M Nowak, Judd E Hollander, Philippe Duc, Alan B Storrow, William T Abraham, Paul Clopton, Alan S Maisel, Peter A McCullough.   

Abstract

While anemia is a significant risk factor for poor outcomes in patients with heart failure (HF), it is not in defined guidelines for HF assessment. B-type natriuretic peptide (BNP) is a marker for diagnosis and management of patients with HF. We determined the incidence of anemia in patients with HF and the relationship between BNP and hemoglobin (Hgb) levels in patients with and without HF. Results from the Breathing Not Properly Multinational Trial consisted of 1,586 patients presenting to the emergency department (ED) with dyspnea. Because renal insufficiency is a confounding variable for BNP, patients with a creatinine of >or=2.0 mg/dL were excluded. The remaining data were evaluated from 620 non-HF patients (337 M, 283 F) and 547 HF patients (299 M, 248 F). The New York Heart Association (NYHA) HF classification and ejection fraction by echocardiography were assessed for HF patients. Blood was tested for Hgb, BNP, and creatinine. Using World Health Organization criteria for anemia, we observed that HF patients in NYHA class III or IV had lower mean Hgb levels (12.5 g/dL, P < 0.05) and a higher incidence of anemia (48.2%, P < 0.05) than did HF patients in class I or II (13.4 g/dL and 33.9%, respectively). There was no correlation between Hgb and log BNP for females without HF or the aggregate of all HF patients. In contrast, a significant inverse correlation was observed for males without HF (P < 0.001). Although there were differences in the BMI, age, and estimated glomerular filtration rate (eGFR) versus Hgb observed in this group, the log BNP correlation remained significant after multivariate analysis. A significant inverse correlation for log BNP and Hgb were also observed for diastolic (EF >or= 50) HF (P < 0.05) that was also not accounted for by the BMI, age, or eGFR. The presence of anemia is associated with worsening HF at ED presentation. For males without HF and diastolic HF patients of both genders, a low Hgb may be a confounding variable toward increasing BNP. Among systolic HF patients, the presence of a low hemoglobin concentration is not a factor in the interpretation of BNP results.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247751     DOI: 10.1002/ajh.20456

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  12 in total

Review 1.  N-TproBNP as biomarker in systemic sclerosis.

Authors:  Tommaso Schioppo; Carolina Artusi; Teresa Ciavarella; Francesca Ingegnoli; Antonella Murgo; Silvana Zeni; Cecilia Chighizola; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

2.  Relation of brain natriuretic peptide levels to cognitive dysfunction in adults > 55 years of age with cardiovascular disease.

Authors:  John Gunstad; Athena Poppas; Steven Smeal; Robert H Paul; David F Tate; Angela L Jefferson; Daniel E Forman; Ronald A Cohen
Journal:  Am J Cardiol       Date:  2006-06-28       Impact factor: 2.778

3.  Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.

Authors:  Peter A McCullough; Denise Barnard; Robert Clare; Stephen J Ellis; Jerome L Fleg; Gregg C Fonarow; Barry A Franklin; Ryan D Kilpatrick; Dalane W Kitzman; Christopher M O'Connor; Ileana L Piña; Udho Thadani; Vinay Thohan; David J Whellan
Journal:  Clin Cardiol       Date:  2013-08-08       Impact factor: 2.882

4.  Correlates of N-terminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American Study of Kidney Disease and Hypertension.

Authors:  S Yi; G Contreras; E R Miller; L J Appel; B C Astor
Journal:  Am J Nephrol       Date:  2008-09-29       Impact factor: 3.754

Review 5.  Biomarkers in heart failure: a clinical review.

Authors:  J Paul Rocchiccioli; John J V McMurray; Anna F Dominiczak
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

Review 6.  Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.

Authors:  A Palazzuoli; M Gallotta; I Quatrini; R Nuti
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

7.  Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography.

Authors:  Yong Liu; Yi-ting He; Ning Tan; Ji-yan Chen; Yuan-hui Liu; Da-hao Yang; Shui-jin Huang; Piao Ye; Hua-long Li; Peng Ran; Chong-yang Duan; Shi-qun Chen; Ying-ling Zhou; Ping-yan Chen
Journal:  J Am Heart Assoc       Date:  2015-04-17       Impact factor: 5.501

8.  The Effect of Amlodipine and Sildenafil on the NT-ProBNP Level of Patients with COPD-Induced Pulmonary Hypertension.

Authors:  Babak Sharif-Kashani; Ali Hamraghani; Jamshid Salamzadeh; Mohammad Abbasi Nazari; Majid Malekmohammad; Neda Behzadnia; Fanak Fahimi
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 9.  Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions.

Authors:  Michael A Burke; William G Cotts
Journal:  Heart Fail Rev       Date:  2007-03-08       Impact factor: 4.654

10.  Potential determinants of the E/e' ratio in non-dialysis compared with dialysis patients.

Authors:  Hon-Chun Hsu; Gavin R Norton; Chanel Robinson; Angela J Woodiwiss; Patrick H Dessein
Journal:  Nephrology (Carlton)       Date:  2021-07-27       Impact factor: 2.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.